Latest news

Successful H2020 grant

Avidin as part of a European consortium leaded by the Burgos University (Spain) successfully won a H2020 grant (PHC-14-2015) entitled „Novel therapeutic approaches for the

AVIDIN’s Miniconference & Workshop

MINICONFERENCE & WORKSHOP Avidin organized a Miniconference & Workshop entitled “TOP LIFE SCIENCE METHODS – Label-free and traditional methods to analyze cellular response to natural

New Product – SingleCellProtect

SingleCellProtectTM (Cat# SCP-50, SCP-250) solution is an aqueous, nontoxic reagent that induces cell lysis, stabilizes and protects cellular RNA. It is compatible with reverse transcription,

New Products – MycoKill, MycoQuant

In cell culturing mycoplasma contamination is a major problem regarding both research and industrial production. Unlike fungal or bacterial infections, mycoplasmal contaminations cannot be detected

New Patent by IP Australia

New patent, entitled ‘8 Hidroxy-Quinoline Derivatives’ was granted by the Australian Patent Office under patent number 2011256989 on 4th December 2014.

New Patent by US Patent Office

New patent, entitled ‘8 Hidroxy-Quinoline Derivatives’ was granted by the US Patent Office under patent number US 8,871,937 B2 on 28th October 2014.